Levy J A, Mackewicz C E, Barker E
Cancer Research Institute, University of California San Francisco 94143-0128, USA.
Immunol Today. 1996 May;17(5):217-24. doi: 10.1016/0167-5699(96)10011-6.
Noncytotoxic CD8+ T cells may play a critical role in preventing progression to disease following human immunodeficiency virus (HIV) infection. This antiviral response, mediated by a novel CD8+ T-cell antiviral factor (CAF), occurs soon after infection and is maintained in asymptomatic individuals. Here, Jay Levy and colleagues propose that this antiviral activity represents a natural cellular immune reaction that controls HIV production and protects the host from potential harmful effects of cytotoxic T lymphocytes.
无细胞毒性的CD8 + T细胞可能在预防人类免疫缺陷病毒(HIV)感染后疾病进展中发挥关键作用。这种由新型CD8 + T细胞抗病毒因子(CAF)介导的抗病毒反应在感染后不久就会出现,并在无症状个体中持续存在。在此,杰伊·利维及其同事提出,这种抗病毒活性代表了一种天然的细胞免疫反应,可控制HIV的产生,并保护宿主免受细胞毒性T淋巴细胞潜在的有害影响。